文献速递外周动脉疾病主动脉疾病

胸股旁路术在血管质量倡议中的结局分析

Thoracofemoral bypass outcomes in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2020-12-16

基于血管质量倡议数据库2009至2019年154例因闭塞性疾病行胸股旁路术的患者,围术期主要并发症发生率为31.2%,30天生存率95.5%,1年生存率92.7%±2.2%,1年初级通畅率89.0%。用于间歇性跛行时并发症率较高,提示该人群应极少使用胸股旁路术。

要点

  • 胸股旁路术围术期主要并发症发生率达31.2%,需谨慎选择患者。
  • 用于跛行患者时主要并发症率34.8%,提示该人群应极少使用。
  • 肢体挽救指征下胸股旁路术的长期生存和通畅率可接受。

核心结论

  • 胸股旁路术围术期主要并发症发生率高,但用于肢体挽救时长期生存率和通畅率可接受。
  • 用于间歇性跛行时并发症率较高,提示该人群应极少使用胸股旁路术。

研究设计与样本

  • 回顾性描述性分析,使用血管质量倡议 suprainguinal bypass 模块识别2009至2019年因闭塞性疾病行胸股旁路术的154例患者。
  • 比较不同手术指征的主要并发症,分类变量用χ2检验,连续变量用方差分析,Kaplan-Meier法估计生存率和免于大截肢率。

主要发现

  • 手术指征包括跛行66例(42.9%)、静息痛59例(38.3%)、组织缺损19例(12.3%)、急性肢体缺血10例(6.5%)。
  • 主要并发症(如伤口感染、呼吸系统、主要卒中、新发透析、心脏、栓塞、大截肢、闭塞)发生于31.2%的队列。
  • 30天生存率95.5%,Kaplan-Meier估计1年生存率92.7%±2.2%。
  • 出院时初级通畅率92.9%,1年89.0%;1年免于大截肢率97.1%±2.2%,1年总体免于闭塞率96.8%。

临床怎么用

  • 胸股旁路术可用于肢体挽救指征的选择性患者,但需告知围术期主要并发症高风险。
  • 对间歇性跛行患者应极少选择胸股旁路术,因围术期并发症率较高。
  • 这些数据可用于术前患者咨询和决策辅助。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thoracofemoral bypass (TFB) has been used infrequently but is an alternative for select patients with aortoiliac occlusive disease. Limited data are available in the reported data regarding TFB, with all studies small, single-center series. We aimed to describe the perioperative and long-term survival, patency, and rate of major perioperative complications after TFB in a large national registry. METHODS: The Vascular Quality Initiative suprainguinal bypass module was used to identify patients who had undergone TFB for occlusive disease from 2009 to 2019. A descriptive analysis was performed to provide the rates of survival, patency, major complications, and freedom from major amputation in the perioperative period and at 1 year of follow-up. Major complications were compared by procedure indication, with categorical variables analyzed using χ2 tests and continuous variables using analysis of variance. Kaplan-Meier curve analysis was used to estimate survival at the 1- and 5-year follow-up intervals and freedom from major amputation at 1 year. RESULTS: A total of 154 TFB procedures were identified. Of the 154 patients, 59 (38.3%) had undergone previous inflow bypass and 22 (14.2%) had undergone previous leg bypass. The procedure indications included claudication (n = 66; 42.9%), rest pain (n = 59; 38.3%), tissue loss (n = 19; 12.3%), and acute limb ischemia (n = 10; 6.5%). Major complications (eg, wound infection, respiratory, major stroke, new dialysis, cardiac, embolic, major amputation, occlusion) occurred in 31.2% of the cohort. When examined by indication, the acute limb ischemia and claudication cohorts had an increased rate of major complications (acute limb ischemia, 60.0%; claudication, 34.8%; critical limb ischemia, 24.4%; P = .05). The survival rate at 30 days was 95.5%, with a Kaplan-Meier estimated 1-year survival rate of 92.7% ± 2.2%. Primary patency at discharge from the index hospitalization was 92.9% and 89.0% at 1 year. Postoperative major amputation was required for 1 patient during the index hospitalization, for a Kaplan-Meier estimated freedom from major amputation at 1 year of 97.1% ± 2.2%. Two patients developed in-hospital bypass occlusion and three patients developed occlusion within 1 year, for an overall freedom from occlusion rate of 96.8% at 1 year. CONCLUSIONS: TFB is associated with a high rate of perioperative major complications; however, the long-term survival and patency after TFB remained acceptable when performed for limb salvage. The high perioperative complication rates of TFB procedures performed for claudication suggest TFB should be used rarely in this population. These data can be used to counsel patients and aid in decision making before operative intervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stewart LM, Passman MA, Spangler EL, et al. Thoracofemoral bypass outcomes in the Vascular Quality Initiative. J Vasc Surg. 2020. PMID: 33340694. doi:10.1016/j.jvs.2020.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。